课题基金 / 基金详情

2023 Atherosclerosis

2023 Atherosclerosis
2023 动脉粥样硬化
批准号:
10675221
负责人:
Filip K Swirski
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-04-01 至 2024-03-31
关键词:
AcademiaAccelerationAddressAnimal ModelApolipoproteins BAreaArterial Fatty StreakArterial IntimasAsiaAtherosclerosisAustraliaBackBehaviorBlood VesselsCanadaCardiovascular DiseasesCardiovascular systemCause of DeathCell NucleusCell physiologyCellsCessation of lifeChronicCollaborationsCommunicationCommunitiesDataDedicationsDepositionDeveloped CountriesDevelopmentDiabetes MellitusDisabled PersonsDisciplineDiseaseEnsureEnvironmentEquilibriumEuropeEuropeanFosteringGenderGeneticGenetic ScreeningGenomicsGoalsGovernmentHearingHematopoiesisHourImmuneImmune systemImmunologic FactorsImmunologistIncidenceIndividualIndustryInflammationInternationalLaboratoriesLearningLife StyleLipidsLipoproteinsMachine LearningMentorsMetabolicMolecularMorbidity - disease rateMyocardial InfarctionNerve DegenerationNon-Insulin-Dependent Diabetes MellitusObesityPathologicPathway interactionsPatientsPlayPostdoctoral FellowPreventionProductivityRecording of previous eventsReportingResearchResearch PersonnelRisk FactorsRoleScienceScientistShapesSiteSocial InteractionSouth AmericaSpainStrokeStructureStudentsSystemSystems BiologyTechniquesTimeTouch sensationUnderrepresented PopulationsUnited StatesVascular DiseasesVoiceWomanWorkplacearterial remodelingcareercell typecombatcommunecommunity buildingcomorbiditydesigndisorder riskdiversity and inclusionezetimibefightingfrontierhigh dimensionalityhuman modelinformal atmosphereinhibitorinnovationmeetingsmortalitynew therapeutic targetnext generationnovelposterspreventprogramssymposium

项目摘要

项目成果

Filip K Swirski的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract The Gordon Research Conference (GRC) on Atherosclerosis has played a central role in this important field for over 40 years. Although the themes evolve every two years, the format and qualities that make this meeting exceptional are maintained: presentations of cutting-edge unpublished data from leading laboratories within the field and in emerging areas, an environment that encourages open scientific exchange among established and early career investigators from academia, industry and government, and an intimate and inclusive format (<200 attendees) that maximizes productive interactions and discussions between scientists. The goal of the Atherosclerosis GRC conference is to provide a comprehensive overview of research at the cutting edge of the field and the developing frontiers, including the latest and emerging paradigms, the most current techniques for studying atherosclerosis in humans and animal models, and the most promising approaches to prevent and treat cardiovascular disease. The theme of the 2023 meeting is `Molecular mechanisms, genomic modifiers and emerging therapies'. We will: 1) Highlight novel techniques being used to investigate atherosclerosis including high dimensional profiling and spatial organization of vascular and immune cells in the vessel wall, as well as systems biology and machine learning approaches that analyze the atherosclerotic plaque as a whole entity, rather than studying individual cell types as has been done in the past; 2) Discuss new molecular pathways regulating vascular and immune cell function, mechanisms of atherosclerosis regression, immunometabolism, clonal hematopoiesis and genetics of atherosclerosis; 3) Focus on complications of atherosclerosis such as diabetes, myocardial infarction, stroke and neurodegeneration, and 4) Create an inclusive meeting culture that fosters interactions between early and established investigators, welcomes The program will also incorporate short talks and posters from submitted abstracts to capture the latest results and provide ample presentation opportunities for trainees and students. For the first time in 17 years, the Atherosclerosis GRC will be returning to a venue in Europe: the Rey Don Jaime Grand Hotel in Castelldefels, Spain. This site is easily accessed from the United States and Europe (20min from a major airport), and has comprehensive conference facilities, accessible to disabled persons, that accommodate the formal and informal meetings, community meals, and social interactions that make the GRC meetings unique. As the atherosclerosis community is an international group, there has always been strong attendance by our European colleagues of the US-based GRC meetings, and we are excited to bring the meeting closer to them this time. In summary, the Atherosclerosis GRC has been thriving for over 40 years through the support of its strong scientific community and its guiding principles of cutting-edge science, open discussion and inclusion. underrepresented scientists and enables their voices to be heard.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophages in homeostasis and cardiovascular disease
Macrophages in homeostasis and cardiovascular disease
Macrophages in homeostasis and cardiovascular disease
Project 3: Remote control of hematopoiesis in cardiovascular disease
  • 批准号:
    10469353
  • 项目类别:
  • 资助金额:
    $39.98万
  • 财政年份:
    2019
  • 负责人:
    Filip K Swirski
  • 依托单位:
海外基金